CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 1,802 shares at an average $8.41 ($15,147)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 2,125 shares at an average $8.40 ($17,860)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 723 shares at an average $8.40 ($6,076)
- 4 Planned sale Chief Financial Officer sold 482 shares at an average $8.51 ($4,103)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 324 shares at an average $8.40 ($2,723)
- 4 Planned sale Director sold 102 shares at $8.55 ($872)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,461 shares at an average $7.29 ($39,836)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 1,791 shares at an average $7.28 ($13,036)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 2,115 shares at an average $7.25 ($15,333)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 722 shares at an average $7.21 ($5,206)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 306 shares at an average $7.20 ($2,205)
- 4 Open-market sale Chief Financial Officer sold 204 shares at $7.09 ($1,446)
- 4 Open-market sale Chief Financial Officer sold 215 shares at $8.02 ($1,724)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 1,852 shares at an average $7.72 ($14,293)
Page 3 of 16 · 304 filings